Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,109 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00444782 | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | completed | Phase 2 | 41 | Pharmexa A/SINDUSTRY | 3 | Dec 18, 2008 | clinicaltrials |
| NCT00189332 | Use of 852A in Metastatic Cutaneous Melanoma. | completed | Phase 2 | 28 | PfizerINDUSTRY | 3 | Oct 27, 2008 | clinicaltrials |
| NCT00770393 |
| Laryngeal Preservation in Pyriform Sinus Carcinoma |
| completed |
| Phase 2 / Phase 3 |
| 71 |
| Centre Hospitalier Universitaire de Saint EtienneOTHER |
| 1 |
| Oct 10, 2008 |
| clinicaltrials |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | withdrawn | Phase 1 / Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 4 | Aug 29, 2008 | clinicaltrials |
| NCT00006116 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075465 | Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075517 | Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075543 | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00274859 | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer | unknown | Phase 2 | 45 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00303745 | Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | 78 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00720031 | Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones | completed | Phase 1 / Phase 2 | 16 | Nantes University HospitalOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00422786 | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 10 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00600977 | Liposomal Anthracyclin in the Treatment of Elderly ALL | completed | Phase 2 | 60 | French Innovative Leukemia OrganisationOTHER | 1 | Jun 26, 2008 | clinicaltrials |
| NCT00087503 | Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | completed | Phase 2 | 28 | PfizerINDUSTRY | 5 | Apr 1, 2008 | clinicaltrials |
| NCT00059735 | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | completed | Phase 2 | 30 | Eisai Inc.INDUSTRY | 2 | Mar 5, 2008 | clinicaltrials |
| NCT00611754 | Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 15 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00611962 | Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin | completed | Phase 2 | 27 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00333294 | Phase II Iressa + Irradiation Followed by Chemo in NSCLC | completed | Phase 2 | 50 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00536393 | Treatment of Disseminated High Grade Lymphoma | completed | Phase 2 / Phase 3 | 100 | French Innovative Leukemia OrganisationOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00191568 | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 2 | 45 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 19, 2007 | clinicaltrials |
| NCT00129155 | MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies | unknown | Phase 2 | 30 | Hospices Civils de LyonOTHER | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00180921 | Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck | unknown | Phase 2 | 30 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | unknown | Phase 2 | 71 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 18, 2007 | clinicaltrials |
| NCT00189579 | Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer | terminated | Phase 2 | 45 | ARCAGY/ GINECO GROUPOTHER | 1 | Aug 17, 2007 | clinicaltrials |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | completed | Phase 2 / Phase 3 | 300 | Lymphoma Study AssociationOTHER | 2 | Jul 13, 2007 | clinicaltrials |
| NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | unknown | Phase 2 | 33 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 12, 2007 | clinicaltrials |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | completed | Phase 2 | 168 | PfizerINDUSTRY | 9 | May 4, 2007 | clinicaltrials |
| NCT00146913 | AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year | unknown | Phase 2 | 30 | Hospices Civils de LyonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00149136 | Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. | unknown | Phase 2 | 30 | Hospices Civils de LyonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00210002 | Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced | terminated | Phase 2 | 55 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00210028 | Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 40 | Institut Claudius RegaudOTHER | 1 | Nov 14, 2006 | clinicaltrials |
| NCT00349505 | Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma | unknown | Phase 2 | 67 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | suspended | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180830 | Glivec Phase II Pediatric Study | terminated | Phase 2 | 36 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Sep 11, 2006 | clinicaltrials |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | terminated | Phase 2 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180960 | Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia | terminated | Phase 2 | 100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00127049 | Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | unknown | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00138086 | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma | completed | Phase 2 | 75 | Lymphoma Study AssociationOTHER | 3 | Sep 8, 2006 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00034593 | A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 3 | Jul 19, 2006 | clinicaltrials |
| NCT00337506 | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma | terminated | Phase 2 | 50 | Nantes University HospitalOTHER | 1 | Jun 16, 2006 | clinicaltrials |
| NCT00324610 | Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen | unknown | Phase 1 / Phase 2 | 46 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | May 18, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials